The Cochrane database of systematic reviews

Workplace programs to help sick workers avoid long-term disability

Updated

Abstract

Workplace interventions significantly improved time until first return to work (RTW) with a hazard ratio (HR) of 1.55.

  • Fourteen randomized controlled trials (RCTs) with 1897 workers were analyzed, focusing on those with musculoskeletal disorders, mental health issues, and cancer.
  • Workplace interventions did not significantly reduce the time to lasting RTW compared to usual care, with a very low-quality evidence rating.
  • Cumulative duration of sickness absence decreased by an average of -33.33 days, indicating a significant positive effect of workplace interventions.
  • Subgroup analysis showed that workers with musculoskeletal disorders experienced greater improvements in both time to first and lasting RTW compared to usual care.
  • In studies involving mental health problems, significant improvements were observed in time until first RTW, but not in lasting RTW.
  • The evidence quality for workplace interventions aimed at workers with mental health problems and cancer was rated low, indicating limited effectiveness.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Myrthe van Vlisteren: None known. Sandra van Oostrom: I am an author on van Oostrom 2010a. I did not participate in deciding whether to include or exclude this study nor in extracting data from it or in assessing its risk of bias. Henrica de Vet: I am an author on Anema/Steenstra 2007. I did not participate in deciding whether to include or exclude this study nor in extracting data from it or in assessing its risk of bias. Renée‐Louise Franche: I am a private consultant in work disability prevention. I received CAD 800 for giving a keynote address on work disability prevention in a psychology conference in Banff in March 2013. Cécile Boot: None known. Johannes Anema: I am an author on Anema/Steenstra 2007, Lambeek 2010a, van Oostrom 2010a and Vlasveld 2012a. I did not participate in deciding whether to include or exclude these studies nor in extracting data or assessing their risk of bias. I am a consultant for Evalua Netherlands LtD that is selling a health checklist to large employers and insurance companies to improve work ability and reduce future work disability. I also own Evalua Netherlands LtD stocks. I regularly receive travel and accommodation costs and sometimes speaker fees to present research results, including those of this review. I supervise a PhD student funded by a grant from Instituut GAK. I have also received a grant and travel support from Instituut GAK. I am an editor of the Handbook of Work Disability that includes part of the review results. I hold a chair (0.4 FTE) endowed by the Dutch Workers Compensation board.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free